Sarcopenia and Related Factors in Lipedema

Launched by DOKUZ EYLUL UNIVERSITY · Feb 12, 2023

Keywords

ClinConnect Summary

This clinical trial is studying lipedema, a condition that causes painful swelling in the arms and legs, and its connection to sarcopenia, which is the loss of muscle strength and mass as people age. Researchers want to understand whether the muscle weakness seen in patients with lipedema is a direct result of the condition itself or if it’s due to decreased physical activity. By investigating this relationship, the study aims to help find ways to encourage patients with lipedema to stay active, which can improve their overall health and quality of life.

To be eligible for the study, participants must be women aged 18 to 85 who have been diagnosed with lipedema and are willing to take part. Healthy women in a similar age range may also be included as a comparison group. Participants can expect to undergo assessments that will help determine their muscle strength and activity levels. It’s important to note that individuals with certain medical conditions or who have difficulty providing consent will not be included in this study. This research is vital as it could lead to better management strategies for patients living with lipedema.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • between the ages of 18-85
• • with a diagnosis of lipoedema
• • who agreed to participate in the study
• • having a sociocultural level suitable for participation in the study
• • healthy volunteers in a similar age group for the control group
• Exclusion Criteria:
• • with chronic venous insufficiency and/or lymphedema
• • with Parkinson's disease, previous stroke, cerebellar diseases, multiple sclerosis, major depression, neuromuscular diseases, history of major orthopedic surgery, severe hip/knee osteoarthritis, rheumatological diseases, malignancies, advanced heart/liver/renal failure, visual impairment, and vestibular diseases, and those who use any assistive device to walk
• • who are illiterate and have cognitive impairment that will prevent them from giving written consent will not be included in the study